News outlets report on various efforts to develop and test Ebola vaccines.

Associated Press: Johnson & Johnson plans Ebola vaccine testing (10/22).
CQ HealthBeat: J&J Plans More Than 1 Million Ebola Vaccine Doses Next Year (Young, 10/22).
Financial Times: GSK expects first doses of Ebola vaccine ready by year end (Ward, 10/22).
The Hill: NIH launches trial of second Ebola vaccine (Viebeck, 10/22).
Reuters: Drugmakers may need indemnity for fast-tracked Ebola vaccines (Hirschler/Nebehay, 10/23).
Reuters: E.U. earmarks $250 million to help develop Ebola vaccines: sources (Hirschler, 10/22).